RxSight Inc.

26.96
-1.40 (-4.94%)
At close: Mar 03, 2025, 3:59 PM
26.93
-0.11%
After-hours: Mar 03, 2025, 04:55 PM EST

RxSight Income Statement

Year FY24 FY23 FY22 FY21 FY20 FY19
Revenue 139.93M 89.08M 49.01M 22.59M 14.68M 2.24M
Cost of Revenue 40.98M 35.31M 27.68M 18.08M 12.97M 4.06M
Gross Profit 98.94M 53.77M 21.33M 4.52M 1.71M -1.82M
Operating Income -36.86M -50.09M -63.32M -52.79M -35.41M -46.07M
Interest Income 9.47M 6.57M 1.52M 54K 543K 2.31M
Pretax Income -27.41M -48.59M -66.75M -48.68M 27.63M 126.24M
Net Income -27.45M -48.61M -66.76M -48.69M 27.57M 126.22M
Selling & General & Admin 101.43M 74.8M 58.66M 32.8M 15.18M 15.2M
Research & Development 34.37M 29.05M 25.98M 24.5M 21.93M 29.57M
Other Expenses n/a n/a n/a n/a n/a n/a
Operating Expenses 135.8M 103.85M 84.65M 57.3M 37.11M 44.77M
Interest Expense 21K 3.31M 4.95M 3.68M 510K 26K
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a
Cost & Expenses 176.78M 139.16M 112.32M 75.38M 50.08M 48.83M
Income Tax 50K 20K 9K 8K 57K 24K
Shares Outstanding (Basic) 38.87M 34.46M 27.66M 27.37M 27.62M 27.62M
Shares Outstanding (Diluted) 38.87M 34.46M 27.66M 27.37M 27.62M 27.62M
EPS (Basic) -0.71 -1.41 -2.41 -1.78 0.12 0.95
EPS (Diluted) -0.71 -1.41 -2.41 -1.78 0.12 0.95
EBITDA -23.76M -41.04M -57.78M -41.01M 32.15M 130.2M
Depreciation & Amortization 3.62M 4.24M 4.02M 3.99M 4.01M 3.93M